Past and Future of Drug Treatments for Alzheimer's Disease
- 1 January 2018
- journal article
- Published by Korean Neuropsychiatric Association in Journal of Korean Neuropsychiatric Association
- Vol. 57 (1), 30-42
- https://doi.org/10.4306/jknpa.2018.57.1.30
Abstract
Kim SY. J Korean Neuropsychiatr Assoc. 2018 Feb;57(1):30-42. https://doi.org/10.4306/jknpa.2018.57.1.30Keywords
This publication has 82 references indexed in Scilit:
- Antioxidants for Alzheimer DiseaseArchives of Neurology, 2012
- Donepezil and Memantine for Moderate-to-Severe Alzheimer's DiseaseThe New England Journal of Medicine, 2012
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive ImpairmentArchives of Neurology, 2012
- Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer DiseaseJAMA, 2010
- Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind studyClinical Therapeutics, 2010
- Ginkgo biloba for cognitive impairment and dementiaCochrane Database of Systematic Reviews, 2009
- High-Dose B Vitamin Supplementation and Cognitive Decline in Alzheimer DiseaseJama-Journal Of The American Medical Association, 2008
- Long-term Course and Effectiveness of Combination Therapy in Alzheimer DiseaseAlzheimer Disease & Associated Disorders, 2008
- ω-3 Fatty Acid Treatment in 174 Patients With Mild to Moderate Alzheimer Disease: OmegAD StudyArchives of Neurology, 2006
- Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving DonepezilJama-Journal Of The American Medical Association, 2004